Liberum offers next generation protein manufacturing. Taking advantage of our suite of proprietary molecular and hardware technologies, we bring speed, scalability and cost reduction to disrupt current biologics manufacturing practices. Our vision is to democratize access to the fruits of synthetic biology.
Location: Canada, Ontario, Toronto
Employees: 1-10
Investors 3
| Date | Name | Website |
| 09.01.2022 | Velocity | velocityin... |
| - | Transolam | transolam.... |
| 12.06.2021 | Creative D... | creativede... |
Mentions in press and media 7
| Date | Title | Description |
| 15.10.2024 | New cell therapy biotech emerges with $17M, thymus-targeting therapies | Cell therapy biotech Tolerance Bio has unveiled with $17.2 million and a mission of targeting immune diseases by stretching and saving the function of a key organ. The Philadelphia biotech’s seed financing was led by Columbus Venture Partne... |
| 14.04.2022 | ARCH leads $130M infusion into Be Bio’s long pursuit of B cell therapies for rare disease, cancer | - |
| 12.04.2022 | Cell therapy biotech raises $120M to advance therapy to treat common cornea condition | Hazy vision is a symptom of corneal edema secondary to endothelial dysfunction. (Aurion Biotech Image) Aurion Biotech has raised $120 million to advance its cell therapy for an eye disorder that affects millions of people. The startup is a ... |
| 11.04.2022 | Merck extends pact with NK cell specialists at Artiva; Regeneron-allied biotech pencils in $15M IPO | More than a year into its discovery pact with the NK cell specialists at Artiva, Merck is apparently happy with what it’s seen so far. So happy, in fact, that it wants to try new things with the platform. The pharma giant has... |
| 27.10.2020 | Next-gen skincare, silk without spiders and pollution for lunch: Meet the biotech startups pitching at IndieBio’s Demo Day | Biotech can often, and sometimes literally, fly over our heads. However, the pandemic has shown an increased need for investment and focus on solutions that work on human and planetary health. For IndieBio, a science and biotech accelerator... |
| - | Liberum Biotech | “Cell-free protein synthesis systems to make your enzymes, therapeutics and lab reagents faster. Our products will help you express and purify custom recombinant proteins.” |
| - | Cell therapy biotech Aurion gets $120M to restore vision and revamp organ donor economics | When the cells of the innermost layer of the cornea die from disease or injury, they’re lost forever. Unlike some other parts of the eye, the corneal endothelium does not regenerate. Corneal transplants are a treatment option, and while thi... |